PTP1B inhibition promotes microglial phagocytosis in Alzheimer’s disease models by enhancing SYK signaling
Preprint
Abstract
Amyloid-β (Aβ) accumulation is a hallmark of Alzheimer’s disease (AD). Emerging evidence suggests that impaired microglial Aβ phagocytosis is a key feature in AD, highlighting the therapeutic potential of enhancing this innate immune function. Here, we demonstrate that genetic deletion or pharmacological inhibition of protein tyrosine phosphatase 1B (PTP1B) ameliorated memory deficits and reduced Aβ burden in APP/PS1 mice. Moreover, we show that PTP1B was highly expressed in microglia, and its deficiency promoted a transcriptional shift toward immune activation and phagocytosis. Consistently, PTP1B deletion in microglia enhanced phagocytosis and metabolic fitness, supported by increased AKT-mTOR signaling, a pathway essential for meeting the energy demands of activation. Mechanistically, we identified spleen tyrosine kinase (SYK), a key regulator of microglial phagocytosis, as a direct substrate of PTP1B. Inhibition of SYK showed that PTP1B modulates microglial activation in a SYK-dependent manner. These findings established PTP1B as a critical modulator of microglial activation and a potential therapeutic target for AD.Keywords
All Related Versions
Funding Information
- Coins for Alzheimers’ Research Trust
- Dane G. Hansen Foundation
This publication has 74 references indexed in Scilit:
- Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the USAlzheimer's & Dementia, 2024
- Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s diseaseAgeing Research Reviews, 2023
- TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathwaysCell, 2022
- Microglia are SYK of Aβ and cell debrisCell, 2022
- SYK coordinates neuroprotective microglial responses in neurodegenerative diseaseCell, 2022
- TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s DiseaseCell, 2017
- A Unique Microglia Type Associated with Restricting Development of Alzheimer’s DiseaseCell, 2017
- Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- Brain metabolic dysfunction at the core of Alzheimer's diseaseBiochemical Pharmacology, 2014
- A Brake Becomes an Accelerator: PTP1B—A New Therapeutic Target for Breast CancerCancer Cell, 2007